2025-07-28 - Analysis Report
Okay, here's a report analyzing Natera Inc. (NTRA) based on the data you provided.

## Natera Inc. (NTRA) Stock Analysis

**Company Overview:** Natera Inc. is a diagnostics company specializing in cell-free DNA testing.

### 1. Performance vs. S&P 500 (VOO)

*   **NTRA Cumulative Return:** 117.19%
*   **VOO Cumulative Return:** 99.96%
*   **Absolute Spread (NTRA - VOO):** 18.9 (NTRA 아웃퍼폼)
*   **Relative Spread:** 8.7 (과거 데이터 범위에서 8.7 분위에 위치)

**Analysis:** NTRA has outperformed the S&P 500, with a 18.9% higher cumulative return. However, the relative spread suggests that this outperformance is not extreme compared to its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD   | Alpha    | Beta   | Cap(B) |
|------------|----------|-------|----------|--------|--------|
| 2015-2017  | -6.0%    | 62.4% | -31.0%   | 0.0    | 1.2    |
| 2016-2018  | 29.0%    | 80.1% | 11.0%    | 0.0    | 1.9    |
| 2017-2019  | 159.0%   | 80.1% | 130.0%   | 1.2    | 4.6    |
| 2018-2020  | 530.0%   | 80.1% | 510.0%   | 0.3    | 13.6   |
| 2019-2021  | 355.0%   | 62.9% | 307.0%   | 0.2    | 12.8   |
| 2020-2022  | -119.0%  | 62.9% | -121.0%  | 0.2    | 5.5    |
| 2021-2023  | -482.0%  | 69.9% | -500.0%  | 1.1    | 8.6    |
| 2022-2024  | -75.0%   | 70.6% | -100.0%  | 1.2    | 21.6   |
| 2023-2025  | 66.0%    | 75.2% | 14.0%    | 0.8    | 19.0   |

**Analysis:**

*   **CAGR:**  CAGR varies significantly. 과거에 높은 성장을 기록했으나 최근에는 하락세를 보임
*   **MDD:**  High Maximum Drawdown indicates significant price volatility and risk.
*   **Alpha:** Alpha is highly variable. S&P 500보다 높은 성과를 냈다가 뒤쳐지는 경우도 발생
*   **Beta:** Beta values fluctuate, indicating changing volatility compared to the market.
*   **Cap:**  Market capitalization has grown over time, although it fluctuates.

### 2. Recent Price Action

*   **Current Price:** 138.90
*   **Previous Close:** 141.07
*   **Change:** -1.53% (하락)
*   **5-Day Moving Average:** 139.67
*   **20-Day Moving Average:** 153.06
*   **60-Day Moving Average:** 157.76

**Analysis:** The stock is trading below its 5, 20, and 60-day moving averages, suggesting a short-term downward trend.  The recent price decrease of -1.53% indicates continued selling pressure.

### 3. Technical Indicators and Outlook

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 24.95 (Oversold)
*   **PPO:** -1.24
*   **Hybrid Signal:** cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.33)
*   **Delta Previous Relative Divergence (20-day):** -0.4 (단기 하락)
*   **Expected Return:** 191.6% (Over 2 years, vs. S&P 500)

**Analysis:**

*   **MRI:** Indicates low market risk.
*   **RSI:** The RSI is in oversold territory, suggesting a potential bounce.
*   **PPO:** Negative PPO indicates a downward trend.
*   **Hybrid Signal:** Suggests selling a small portion of holdings with a high cash position.
*   **Delta Previous Relative Divergence:** Further confirms short-term downward momentum.
*   **Expected Return:**  While the expected return is high, this is a long-term estimate and should be viewed cautiously given the stock's volatility.

### 4. Recent News & Significant Events

*   **2025-07-28:** Major business developments, regulatory changes, or market events.
*   **2025-07-26:** Analyst discussion on performance, industry trends, and global economic factors.
*   **2025-07-27:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-24:** Market experts highlight both risks and opportunities, advising monitoring of news and company announcements.

**Analysis:** Recent news suggests volatility and potential impacts from both company-specific events and broader market conditions. Investors should closely monitor news and announcements.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출     |
|------------|-------|----------|
| 2025-05-09 | -0.50 | 0.50 B$  |
| 2024-11-12 | -0.26 | 0.44 B$  |
| 2024-08-09 | -0.30 | 0.41 B$  |
| 2024-05-10 | -0.56 | 0.37 B$  |
| 2025-05-09 | -0.56 | 0.37 B$  |

**Analysis:**

*   **EPS:** Negative EPS values indicate continued losses.
*   **Revenue:** Revenue has been increasing, suggesting growth, but not enough to offset losses yet.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $0.50B    | 63.12%        |
| 2024-12-31 | $0.48B    | 62.94%        |
| 2024-09-30 | $0.44B    | 61.79%        |
| 2024-06-30 | $0.41B    | 58.83%        |
| 2024-03-31 | $0.37B    | 56.72%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-03-31 | $1.24B    | -5.40%    |
| 2024-12-31 | $1.20B    | -4.50%    |
| 2024-09-30 | $0.88B    | -3.60%    |
| 2024-06-30 | $0.84B    | -4.48%    |
| 2024-03-31 | $0.79B    | -8.51%    |

**Analysis:**

*   **Revenue and Profitability:** Revenue has shown consistent growth. Profit margins are relatively high and increasing.
*   **Capital and Profitability:** Equity is growing, but the negative ROE reflects the company's ongoing losses.

### 7. Overall Analysis and Conclusion

Natera Inc. (NTRA) presents a mixed picture. While the company has shown strong revenue growth and high profit margins, it continues to experience losses (negative EPS and ROE). The stock has outperformed the S&P 500, but recent price action indicates a short-term downward trend.

**Key Takeaways:**

*   **Growth Potential:**  Strong revenue growth and improving profit margins suggest potential for future profitability.
*   **Risk Factors:** Continued losses, high volatility (high MDD), and sensitivity to market news and events (as indicated by the recent news and volatility) are significant risks.
*   **Technicals:**  The oversold RSI suggests a potential bounce, but the downward trend indicated by moving averages and PPO warrants caution.
*   **Hybrid Signal:** Cautious signal suggests reducing exposure.
*   **Long-Term Outlook:**  The high expected return is attractive, but it's essential to consider the risks and volatility associated with NTRA.

**Recommendation:**

Given the high volatility, negative profitability, and recent downward price trend, a cautious approach is warranted. Investors should closely monitor company news, earnings reports, and broader market conditions before making investment decisions. Further analysis of the underlying business fundamentals and competitive landscape is recommended.
